Antipsychotic agents: efficacy and safety in schizophrenia [PDF]
Drug, Healthcare and Patient Safety, 2012Arão Nogueira de Araújo,1 Eduardo Pondé de Sena,1,2 Irismar Reis de Oliveira,1,3 Mario F Juruena41Postgraduation Program in Interactive Processes of Organs and Systems, 2Department of Pharmacology, Institute of Health ...
de Araújo AN+3 more
doaj +7 more sources
Antibacterial activity of antipsychotic agents, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity. [PDF]
PLoS One, 2018Bacterial antibiotic resistance is an emerging public health problem worldwide; therefore, new therapeutic strategies are needed. Many studies have described antipsychotic compounds that present antibacterial activity.
Nehme H+6 more
europepmc +4 more sources
Association of Selected Antipsychotic Agents With Major Adverse Cardiovascular Events and Noncardiovascular Mortality in Elderly Persons. [PDF]
J Am Heart Assoc, 2015Background Data from observational studies have raised concerns about the safety of treatment with antipsychotic agents (APs) in elderly patients with dementia, but this area has been insufficiently investigated. We performed a head-to-head comparison of
Sahlberg M+5 more
europepmc +4 more sources
Use of second-generation antipsychotic agents for sleep and sedation: a provider survey. [PDF]
Sleep, 2013OBJECTIVES Anecdotal evidence suggests that second-generation antipsychotic agents are increasingly used to treat sleep problems. This study sought to quantify the proportion of new prescriptions for second-generation antipsychotic agents started for ...
Hermes ED, Sernyak M, Rosenheck R.
europepmc +4 more sources
Antipsychotic Agents: A Clinical Update [PDF]
Mayo Clinic Proceedings, 1985Antipsychotic agents have many indications and are frequently used. All physicians, regardless of their subspecialty, will most likely treat patients who receive these drugs. This article is designed to help nonpsychiatric physicians use antipsychotics appropriately.
Jarrett W. Richardson+2 more
openaire +4 more sources
QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy [PDF]
Annals of General Psychiatry, 2005Background Several antipsychotic agents are known to prolong the QT interval in a dose dependent manner. Corrected QT interval (QTc) exceeding a threshold value of 450 ms may be associated with an increased risk of life threatening arrhythmias ...
Piccinelli Marco+9 more
doaj +5 more sources
Existing and emerging pharmacological approaches to the treatment of mania: A critical overview [PDF]
Translational Psychiatry, 2022Manic episodes are a defining, frequent and dramatically disabling occurrence in the course of Bipolar Disorder type I. Current pharmacotherapy of mania lists a good number of agents, but differences in efficacy and safety profiles among these agents ...
Giulio Sparacino+3 more
doaj +2 more sources
Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia
Neuropsychiatric Disease and Treatment, 2009Xinhua S Ren1,2,3, Lawrence Herz4,5, Shirley Qian1,2,3, Eric Smith3,4, Lewis E Kazis1,2,31The Center for the Assessment of Pharmaceutical Practices (CAPP), Boston University School of Public Health, Boston, MA, USA; 2Department of ...
Xinhua S Ren+3 more
doaj +2 more sources
Advances and Challenges in Intranasal Delivery of Antipsychotic Agents Targeting the Central Nervous System. [PDF]
Front Pharmacol, 2022Pandey M+4 more
europepmc +3 more sources
Association between antipsychotic agents and risk of lung cancer: a nested case-control study. [PDF]
Cancer Commun (Lond), 2022Li J, Tang F, Si S, Xue F.
europepmc +3 more sources